Literature DB >> 27094597

Oxidative stress and Kawasaki disease: how is oxidative stress involved from the acute stage to the chronic stage?

Tomoyo Yahata1, Kenji Hamaoka2.   

Abstract

Inflammation and oxidative stress are closely related. Further, oxidative stress plays an important role in the pathology of inflammation-based Kawasaki disease. An excessive in vivo production of reactive oxygen species increases oxidative stress in the body, which triggers an endless vicious spiral of inflammation reactions and reactive oxygen metabolites. This presumably forms diffuse vasculitis in the acute phase. Acute inflammation and oxidative stress can be rapidly controlled by treatments; however, they may remain for a long time. This has recently been identified as a problem in the chronic phase of Kawasaki disease. Generally, the presence of vascular inflammation and oxidative stress impairs blood vessels, leading to the onset of atherosclerosis, which is a widely recognized risk. The current discussion focuses on whether the same is valid for blood vessels in the chronic phase of Kawasaki disease.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Kawasaki disease; arteriosclerosis; oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 27094597     DOI: 10.1093/rheumatology/kew044

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  10 in total

1.  Oxidised Low-Density Lipoprotein and Its Receptor-Mediated Endothelial Dysfunction Are Associated with Coronary Artery Lesions in Kawasaki Disease.

Authors:  Yue-E He; Hui-Xian Qiu; Rong-Zhou Wu; Xing Rong; Hai-Tang Xu; Ru-Lian Xiang; Mao-Ping Chu
Journal:  J Cardiovasc Transl Res       Date:  2019-08-19       Impact factor: 4.132

2.  Phase I/IIa Trial of Atorvastatin in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysm.

Authors:  Adriana H Tremoulet; Sonia Jain; Pei-Ni Jone; Brookie M Best; Elizabeth H Duxbury; Alessandra Franco; Beth Printz; Samuel R Dominguez; Heather Heizer; Marsha S Anderson; Mary P Glodé; Feng He; Robert L Padilla; Chisato Shimizu; Emelia Bainto; Joan Pancheri; Harvey J Cohen; John C Whitin; Jane C Burns
Journal:  J Pediatr       Date:  2019-09-24       Impact factor: 4.406

3.  Melatonin alleviates vascular endothelial cell damage by regulating an autophagy-apoptosis axis in Kawasaki disease.

Authors:  Yuanzheng Zheng; Saihua Huang; Jialing Zhang; Jia Hou; Fang Wu; Wenji Wang; Xiao Han; Yonghao Gui
Journal:  Cell Prolif       Date:  2022-05-17       Impact factor: 8.755

4.  Antioxidant properties of flavonoid derivatives and their hepatoprotective effects on CCl4 induced acute liver injury in mice.

Authors:  Cen Xiang; Yuou Teng; Chaoran Yao; Xuehui Li; Menglin Cao; Xuzhe Li; Guojun Pan; Kui Lu; Hervé Galons; Peng Yu
Journal:  RSC Adv       Date:  2018-04-24       Impact factor: 4.036

Review 5.  Kawasaki Disease: Pathology, Risks, and Management.

Authors:  Mitsuru Seki; Takaomi Minami
Journal:  Vasc Health Risk Manag       Date:  2022-06-10

6.  Hydrogen Gas Inhalation Regressed Coronary Artery Aneurysm in Kawasaki Disease-Case Report and Article Review.

Authors:  Ho-Chang Kuo
Journal:  Front Cardiovasc Med       Date:  2022-05-12

7.  Differentially expressed genes, lncRNAs, and competing endogenous RNAs in Kawasaki disease.

Authors:  Changsheng Guo; Yuanqing Hua; Zuanhao Qian
Journal:  PeerJ       Date:  2021-05-12       Impact factor: 2.984

8.  Predictive value of brachial artery flow-mediated dilation on coronary artery abnormality in acute stage of Kawasaki disease.

Authors:  Yizhou Wen; Xianmin Wang; Yonghong Guo; Mei Jin; Jimei Xi; Tingting Chen; Kun Shi; Yaheng Lu
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.379

9.  Serum proteins may facilitate the identification of Kawasaki disease and promote in vitro neutrophil infiltration.

Authors:  Sung-Chou Li; Kuo-Wang Tsai; Lien-Hung Huang; Ken-Pen Weng; Kuang-Jen Chien; Yuyu Lin; Chi-Ying Tu; Pei-Hsien Lin
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379

10.  Elevated Plasma Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor-1 Levels in Refractory Kawasaki Disease.

Authors:  Yu-Ran Lee; Eun Young Bae; Hong Ryang Kil; Byeong-Hwa Jeon; Geena Kim
Journal:  Biomedicines       Date:  2022-01-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.